Latest Financial Health News

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Audinate reported a 33% revenue decline in FY25 due to OEM inventory adjustments but boosted gross margins to 82.1% through a software shift and completed the strategic Iris acquisition, setting the stage for growth in FY26.

GWA Group Limited has launched a $30 million on-market share buyback program, balancing capital return with ongoing investment in growth. The move underscores management's confidence in the company’s financial strength and outlook.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

Fiducian Group Limited has reported a solid 23.5% rise in net profit for the 2025 financial year, alongside a 10.6% increase in revenue and a higher fully franked final dividend of 24.7 cents per share.

Bluescope Steel Limited has announced a final dividend of 30 cents per share, 50% franked, payable in October 2025. This dividend reflects the company’s steady financial position for the year ending June 2025.

Contact Energy Limited has announced a total dividend of NZD 0.2529 per share for the six months ending June 2025, including an ordinary and supplementary dividend, with a Dividend Reinvestment Plan available.

The a2 Milk Company reported a robust 13.5% revenue increase and a 21.1% rise in net profit for the fiscal year ending June 2025, alongside healthy dividend declarations.

NGE Capital Limited reported a steady half-year profit increase alongside a notable rise in net tangible assets per share, continuing its share buy-back program and initiating new investments.

EQ Resources has finalized a US$7.5 million royalty funding agreement with Oaktree Capital Management to support its Barruecopardo tungsten project, while major shareholder Cronimet Asia converts a US$3 million offtake prepayment into equity, strengthening the company’s capital position.

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.